Researchers from Harvard University and the Massachusetts Institute of Technology have advanced the fight against HIV by pinpointing the virus's key vulnerability through advanced computational analysis.
No cure exists yet for the life-threatening HIV virus, which weakens the immune system and can progress to AIDS. However, this finding offers hope: scientists have identified ways to halt mutations in critical virus components.
A prime target
HIV contains specific amino acid groups that rarely mutate. The virus relies on these stable segments for survival. Disrupting them could cripple the entire virus. Harvard and MIT researchers propose these as primary targets for next-generation HIV drugs.
Read also: Medication can prevent HIV transmission
The breakthrough
HIV's rapid mutations have long challenged treatment efforts. In this study, the team analyzed various HIV proteins using statistical methods to map segments least prone to change.
This explains rare cases where patients naturally control HIV without drugs—their immune systems target these stable regions.
More about the HIV virus
New drugs on the horizon
The U.S. team plans to develop drugs targeting these vulnerabilities, with initial testing in monkeys.
The findings appear in the journal Proceedings of the National Academy of Sciences.
